---
title: "Sirnaomics shareholders approve 2026 RSU scheme at EGM"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291277166.md"
description: "Sirnaomics shareholders approved the 2026 RSU and Share Option Schemes at an extraordinary general meeting on June 30, 2026. The board is authorized to implement these new schemes, while the previous 2022 RSU and Share Option Schemes were terminated."
datetime: "2026-06-30T11:50:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291277166.md)
  - [en](https://longbridge.com/en/news/291277166.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291277166.md)
generator: "portal-rs"
---

# Sirnaomics shareholders approve 2026 RSU scheme at EGM

-   Sirnaomics held an extraordinary general meeting on June 30, 2026. \* Shareholders adopted the 2026 RSU Scheme, authorizing the board to implement it. \* The 2022 RSU Scheme was terminated. \* Shareholders adopted the 2026 Share Option Scheme, authorizing the board to implement it. \* The 2022 Share Option Scheme was terminated, with the Scheme Mandate Limit approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sirnaomics Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260630-12223386), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [02257.HK](https://longbridge.com/en/quote/02257.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Sirnaomics unit RNAimmune Vaccine signs shareholder agreement with Guangzhou Guangjian fund for RMB 30 million investment](https://longbridge.com/en/news/297033077.md)
- [Sirnaomics H1 FY26 loss narrows to US$379,000; revenue remains no revenue](https://longbridge.com/en/news/297317867.md)
- [GoodVision AI, post-merger with Calisa Acquisition, exhibits at TechCrunch Disrupt 2026](https://longbridge.com/en/news/301494959.md)
- [Chery hosts first international test drive of Freelander 8 at user summit](https://longbridge.com/en/news/301487968.md)
- [Hedera: Agent Accounts launch targets mainnet availability - Q2 2027](https://longbridge.com/en/news/301487589.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**